Abstract Submission System is now Closed
Deadline: 11 July 2024 (23:59 BST)
Abstract Submission
Submissions are limited to two abstracts per presenting author. We advise that you register and enter the abstract submission system well in advance of the deadline to ensure that any difficulties can be resolved in time.
Please read the Instructions and Conditions of Acceptance documents before entering the submission system.
- Submit an abstract (max 450 words) in the abstract submission portal in advance of the deadline.
- Presenting Authors must register for the Symposium before 13 September 2024 to secure attendance.
Once the submission deadline has passed, abstracts will be reviewed by the Symposium Programme Committee. We will inform you of the decision in late August and if you have been accepted, we will provide further instructions on how to submit your poster material (PDF) from September, see key dates below.
*Refunds can be made available in the event that you no longer wish to attend due to an abstract being rejected. Please see Symposium registration T&Cs for more information.
Presenter Registration
If you are submitting an abstract, please use the registration link within the abstract portal below by 13 September 2024.
Proposed poster themes
- Epidemiology and Informatics (EPI)
- Genetics and genomics (GEN)
- In vitro experimental models (IVT)
- In vivo experimental models (IVV)
- Human cell biology and pathology (HCB)
- Tissue biomarkers (BIO)
- Pre-clinical therapeutic strategies (TST)
- Clinical imaging and electrophysiology (IMG)
- Clinical trials and trial design (CLT)
- Disease stratification and phenotyping of patients (DSP)
- Cognitive and psychological assessment and support (COG)
- Clinical management and support (CMS)
Key dates
| Notification of abstract decision | August 2024 |
| Withdrawal deadline | 4 September 2024 (23:59 UK time) |
| Poster submission (PDF) opens | September 2024 |
| Poster submission (PDF) deadline | 18 November 2024 (23:59 UK time) |
| Abstract book published on website | Early November 2024 |
| Symposium | 6-8 December 2024 |
You can sign up for regular Symposium updates by contacting symposium@mndassociation.org so that you don't miss any important dates and announcements. If you have any specific abstract-related queries, please use the contact form below.
Abstract Submission Information and FAQs
Authors will be asked to assign a theme to their abstract in the abstract submission portal. The themes are as follows:
- Epidemiology and Informatics (EPI)
- Genetics and genomics (GEN)
- In vitro experimental models (IVT)
- In vivo experimental models (IVV)
- Human cell biology and pathology (HCB)
- Tissue biomarkers (BIO)
- Pre-clinical therapeutic strategies (TST)
- Clinical imaging and electrophysiology (IMG)
- Clinical trials and trial design (CLT)
- Disease stratification and phenotyping of patients (DSP)
- Cognitive and psychological assessment and support (COG)
- Clinical management and support (CMS)
Submissions are limited to two abstracts per presenting author.
No, authors do not need to register before submitting an abstract. Presenting author's will be required to pay the appropriate in-person registration fee. Formal acceptance of an abstract is conditional upon payment of the full registration fee. Refunds will be available in the event of an abstract being rejected.
Abstracts will be published in an online open access supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. This abstract book will be published online on the Taylor and Francis website and will be found via the Symposium website (symposium.mndassociation.org). Abstracts accepted as ‘WIP/CP’ will be published on the MND Association’s Symposium website.
By submitting an abstract, you consent to give us the license to act on your behalf with the Taylor & Francis group to publish your abstract in the symposium supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
WIP/CP stands for work in progress/care practice. WIP/CP is defined as: preliminary work (little or no data/results), care practice or case studies.
Yes, abstracts may be submitted even if previously presented at a national/international meeting.
Once the submission deadline has passed, abstracts will be reviewed by the Symposium Programme Committee. We will inform you of the decision in late August and if you have been accepted. This will be followed by a second notification in September which will include specific presentation theme/session, time and date information. Poster presenters will also receive details and instructions on poster guidelines and how to submit their poster material (poster PDF) to our virtual platform for our virtual delegates before the upload deadline of 18 November 2024.
The review committee will first review your abstract and select the oral talks from those listed, any not selected may be offered a poster presentation instead.